drugset / Trial / NCT00231660
A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy (in terms of weight and hemoglobin type A1c \[HbA1c\]) and safety of topiramate (96 milligrams\[mg\] or 192 mg daily) with placebo in the treatment of obesity in Type 2 diabetic patients receiving metformin.
Timeline
- Start
- 2000-10
- Primary completion
- —
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 96 mg | Oral |
| Subject | Topiramate | Small molecule | 192 mg | Oral |